LONGEVA.

GHRP-6: adverse events and evidence limits

An overnight IV GHRP-6 study in healthy men found ACTH and cortisol increases compared with placebo. [1]

These hormonal changes are not clinical AE frequencies; the retrieved truncated abstract supplies no such frequencies. [1]

What the studies reported

EffectModel or participantsHow often or as describedSource
ACTH increaseHealthy men, intravenous administration, overnight studyIncreased compared with placebo; a hormonal change, not a clinical adverse-event frequency[1]
Cortisol increaseThe same participantsIncreased compared with placebo; the truncated abstract supplies no clinical adverse-event frequencies[1]

References

  1. R M Frieboes et al. (1995). Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man https://doi.org/10.1159/000126883.